High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment
Status:
Completed
Trial end date:
2018-11-02
Target enrollment:
Participant gender:
Summary
Dual therapy for Helicobacter Pylori including a proton pump inhibitor (PPI) and amoxicillin.
Amoxicillin has low resistance rate as well as low percentage of side effects. No trial has
examined the the efficacy of high dose of dual therapy plus bismuth for H. pylori
treatment.This study is designed to evaluate the efficacy and safety of the addition of
bismuth to high dose of dual therapy for H. pylori eradication.